GSTM1 null allele is a risk factor for gastric cancer development in Asians

Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
Cytokine (Impact Factor: 2.66). 07/2011; 55(1):122-5. DOI: 10.1016/j.cyto.2011.03.004
Source: PubMed


Glutathione S-transferase M1 (GSTM1), which plays an important role in detoxification pathways to protect against damage caused by reactive metabolites of chemicals, has been considered as potential gastric cancer susceptibility genes. However, the published data on the association between GSTM1 present/null polymorphism and gastric cancer risk are still inconclusive. To derive a more precise estimation of the relationship, a meta-analysis was performed. Totally, 44 studies including 5440 cases and 11607 controls were involved in the analysis. When all studies were pooled into the meta-analysis, obviously increased gastric cancer risk was found in null genotype carriers (OR=1.19, 95% CI: 1.08-1.33). When stratified by ethnicity, obviously evaluated risk was found in Asians (OR=1.31, 95% CI: 1.11-1.54) but not reached to statistically significance in Caucasians (OR=1.11, 95% CI: 0.96-1.28). In the subgroup analysis by hospital-based studies or population-based studies, statistically significantly elevated risk was found in hospital-based studies (OR=1.34, 95% CI: 1.07-1.67) but not reached to statistically significance in population-based studies (OR=1.11, 95% CI: 0.99-1.25). In summary, this meta-analysis result indicates that the GSTM1 null genotype is a low-penetrant risk factor for gastric cancer development in Asians.

10 Reads
  • Source
    • "In present work, significant association of GSTM1 polymorphism with GC risk was detected in Asian populations. However, no association was detected in Caucasians, which in line with previous meta-analysis conducted by Qiu et al. [72]. When stratified by source of controls, significant association between GSTM1 polymorphism and GC risk was observed among hospital-based studies. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Glutathione S-transferases (GSTs) have proved to be involved in the detoxifying several carcinogens and may play an important role in carcinogenesis of cancer. Previous studies on the association between Glutathione S-transferase M1 (GSTM1) polymorphism and gastric cancer (GC) risk reported inconclusive results. To get a precise result, we conducted this present meta-analysis through pooling all eligible studies. A comprehensive databases of Pubmed, Embase, Web of Science, and the Chinese Biomedical Database (CBM) were searched for case–control studies investigating the association between GSTM1 null genotype and GC risk. Odds ratios (OR) and 95% confidence intervals (95% CI) were used to assess this possible association. A χ2-based Q-test was used to examine the heterogeneity assumption. Begg’s and Egger’s test were used to examine the potential publication bias. The leave-one-out sensitivity analysis was conducted to determine whether our assumptions or decisions have a major effect on the results of present work. Statistical analyses were performed with the software program STATA 12.0. A total of 47 eligible case–control studies were identified, including 6,678 cases and 12,912 controls. Our analyses suggested that GSTM1 null genotype was significantly associated with increased risk of GC (OR = 1.186, 95% CI = 1.057-1.329, Pheterogenetiy = 0.000, P = 0.004). Significant association was also found in Asians (OR = 1.269, 95% CI = 1.106-1.455, Pheterogenetiy = 0.002, P = 0.001). However, GSTM1 null genotype was not contributed to GC risk in Caucasians (OR = 1.115, 95% CI = 0.937-1.326, Pheterogenetiy = 0.000, P = 0.222). In the subgroup analysis stratified by sources of controls, significant association was detected in hospital-based studies (OR = 1.355, 95% CI = 1.179-1.557, Pheterogenetiy = 0.001, P = 0.000), while there was no significant association detected in population-based studies (OR = 1.017, 95% CI = 0.862-1.200, Pheterogenetiy = 0.000, P = 0.840). This meta-analysis showed the evidence that GSTM1 null genotype contributed to the development of GC. Virtual Slides The virtual slide(s) for this article can be found here:
    Diagnostic Pathology 06/2014; 9(1):122. DOI:10.1186/1746-1596-9-122 · 2.60 Impact Factor
  • Source
    • "A recent study by Wang et al [65] showed that an increased hepatocellular carcinoma risk was significantly affected by the null genotype of GSTM1 among Asians. In addition, a meta-analysis by Qiu et al [66] provided evidences that the GSTM1 null genotype is a low-penetrant risk factor for gastric cancer development only in the Asian population. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Glutathione S-transferase M1 (GSTM1) is thought to be involved in detoxifying several carcinogens and may play a vital role in tumorigenesis. Numerous studies have evaluated the association between GSTM1 null/present polymorphism and risk of prostate cancer (PCa). However, the results remain inconsistent. To derive a more precise estimation, we performed a meta-analysis. A comprehensive search was conducted to identify all eligible case-control studies. We used odds ratios (ORs) with 95% confidence intervals (CIs) to assess the strength of the association. The overall association was significant (OR = 1.28, 95% CI: 1.11-1.48, P = 0.001). Moreover, subgroup analyses showed GSTM1 null genotype significantly associated with PCa risk among Asians (OR = 1.35, 95% CI: 1.03-1.78, P = 0.03) but not among Caucasians (OR = 1.12, 95% CI: 0.96-1.31, P = 0.16). In addition, we did not find that smoking modified the genotype effect on the risk of PCa. The present meta-analysis suggested that GSTM1 null allele was a low-penetrant risk factor for PCa among Asians.
    PLoS ONE 10/2012; 7(10):e46982. DOI:10.1371/journal.pone.0046982 · 3.23 Impact Factor
  • Source
    • "Besides, GSTT1 polymorphism has also been studied extensively in terms of susceptibility for other malignancies. Previous studies have yielded significant associations of GSTT1 polymorphism with risk of gastric cancer, breast cancer, oral cancer, cervical cancer, laryngeal cancer and hepatocellular carcinoma (Qiu et al., 2010; Wang et al., 2010; Kumar et al., 2011; Qiu et al., 2011; Zhang et al., 2011; Zhang et al., 2012), which further suggest GSTT1 polymorphism plays an important role the carcinogenesis and can affect the individual susceptibility to common malignancies. Thus, there is high epidemiological evidence for the association between GSTT1 polymorphism and risk of common cancers. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Background: Glutathione-S-Transferase T1 (GSTT1) gene has been shown to be involved in the development of esophageal cancer. However, the results have been inconsistent. In this study, the authors performed a meta- analysis to clarify the association between GSTT1 polymorphism and esophageal cancer risk among Chinese Han population. Methods: Published literature from PubMed, the China National Knowledge Infrastructure and Wanfang Data were searched. Pooled odds ratio (OR) and 95% confidence interval (95%CI) was calculated using a fixed- or random-effects model. Results: Eleven studies with a total of 2779 individuals were included in the meta-analysis. The results showed that GSTT1 null genotype was significantly associated with esophageal cancer risk in Chinese (OR = 1.31, 95%CI 1.12 to 1.53, p = 0.001). Further sensitivity analyses confirmed the significant association. The cumulative meta-analysis showed a trend of an obvious association between GSTT1 null genotype and esophageal cancer risk as information accumulated by year. Conclusions: This meta-analysis suggests a significant association of GSTT1 null genotype with esophageal cancer risk in the Chinese Han population.
    Asian Pacific journal of cancer prevention: APJCP 09/2012; 13(9):4403-7. DOI:10.7314/APJCP.2012.13.9.4403 · 2.51 Impact Factor
Show more